General Announcement::Outcome of the Board Meeting February 14, 2019

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Feb-2019 15:35:19
Status
New
Announcement Sub Title
Outcome of the Board Meeting February 14, 2019
Announcement Reference
SG190220OTHRPFQ5
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
We wish to inform you that Board at its meeting had given an in-principle approval to spin off the innovation business into a new company in the US.

Kindly find the attached media release regarding the same, which is self-explanatory.

Attachments

SGX_PR_14022019.pdf
Total size =432K